A biotech company’s name may be on a new product, but you can all but guarantee that many people who existed outside of the company also played a critical role in bringing it to market. We tend to assume that the best biotech companies are gigantic organisations that are jam-packed with talented employees, but actually, these companies are often smaller than you might think. Even if they could do things another way, they probably wouldn’t choose to — after all, bringing in outside help offers a wide range of benefits that help to make it a logical strategic decision. 

It Saves Their Time and Focus

There’s a lot that goes into bringing a product to market, and time, energy, and focus are finite resources. Bringing in outside organisations to assist with time-consuming or energy-intensive tasks helps to free up the team’s time, allowing them to focus on value-adding tasks, secure in the knowledge that the other important stuff is being taken care of. It essentially offers the benefits of having a much larger team of staff, without having to go through the process of actually making it a reality. 

It Gives Access to Specialist Knowledge and Resources

In biotech, expertise can be the difference between success and failure. Biotech companies know that, but they also know that they don’t have the budget to hire full-time employees for every specialist role. Outsourcing certain jobs to a third-party company offers a budget-friendly way to get access to the expertise and resources they need. Instead of having to hire a full-time peptide expert, they can simply work with a company that offers peptide research and analysis expertise. Instead of developing their own manufacturing processes, they can partner with an organisation that already has facilities and processes in place. The list goes on; the primary point is that even relatively early-stage biotech companies can get access to the specialist help they need, even if they don’t have the budget to do it themselves in-house. 

It Speeds Things Up

Having to put all the pieces in place to bring a product to market would take years if starting from scratch. Working with other companies allows biotech organisations easy access to the infrastructure and processes they need to take their product to market. It’s not an exaggeration to say that having the right partners can dramatically speed up the development timeline, turning what might have been a multi-year project into one with a timespan of a few months. 

It’s Less Risky

Doing everything in-house can be great when everything runs smoothly, but in the biotech industry, the concept of ‘everything running smoothly’ essentially does not exist. Even successful products undertake a long and challenging journey before reaching the market. Working with others helps to spread the risk, ensuring that the success or failure of the project doesn’t rest squarely on the company’s shoulders. This is especially beneficial to young biotech companies, which can quickly gain much-needed experience by working with others, which can decrease the chances that they’ll make an expensive error.